1 of 1
Story summary
- The FDA approved two oral antibiotics, zoliflodacin and Blujepa, to treat gonorrhea.
- Zoliflodacin is the first new drug targeting gonorrhea in decades.
- Dr. Schaffner of Vanderbilt University notes Tennessee has high gonorrhea rates and stresses access to these medications.
- He states gonorrhea can present differently in men and women and is often asymptomatic in women.
- A study found Blujepa cured 93% of patients, versus 91% for standard treatments.
